Infectious Disease News Current Issue

The following articles appeared in the print edition of Infectious Disease News.

Table of Contents

• Multidisciplinary teams simplify control of foodborne outbreaks
• Flu revaccination in HCWs may prevent 
infection in patients
• Sofosbuvir effectively treated patients with HCV genotypes 2, 3 in phase 3 study
• CDC: Youth account for one-quarter of new HIV infections
• Telavancin recommended as last resort for nosocomial pneumonia
• Great progress made in infectious disease during 2012 Paul A. Volberding, MD
• FDA approves Flucelvax influenza vaccine
• Nasopharyngeal carcinoma in an HIV-positive patient with cranial nerve defects Munir Ghesani, MD, FACNM; Esha Gollapalle, MD; Michael Chung, MD; Ippolito Modica, MD; Daniel E. Meltzer, MD
• A third dose of MMR vaccine may result in decreased disease spread during a mumps outbreak
• Adenovirus detected in few allogeneic HSCT patients
• Antiviral therapy reduced risk for HBV-related tumor recurrence after liver resection
• Beijing strain of TB not associated with drug resistance
• Better detection methods needed for Mycoplasma pneumoniae
• Candidemia still a significant burden in US
• Cetuximab conferred benefits regardless of tumor HPV status
• Challenges remain with EHRs in protecting privacy for adolescents
• Children in Calif. pertussis outbreak less likely to receive five-dose DTaP series
• Clinical practice guidelines for CAP had minimal effect on resource use
• Deworming failed to delay HIV progression in helminth coinfections
• Earnings of US physicians grow less than other health professionals
• Exclusive breast-feeding best to protect against Cronobacter
• Fewer reproductive complications seen, despite increased chlamydia rates
• Flu, fever during pregnancy may raise child’s risk for autism
• Influenza burden shifted during the 2009-2010 pandemic
• Kissing linked to primary EBV infection in college students
• Malaria vaccine produced modest benefits in African infants
• Many adolescents with perinatal HIV infection engage in unprotected sex
• Maternal malaria prevention reduced neonatal mortality, low birth weight
• New drugs, vaccines needed for bacterial meningitis
• NPWT decreases deep infection rate in open tibial fractures
• Optimal dosing of lopinavir/ritonavir crucial in pediatric patients with HIV
• Oseltamivir effective when administered early for H5N1
• PCV13 did not interfere with other routine vaccines
• Prednisolone failed to increase viremia in dengue
• Prognosis may be favorable for HIV-related Hodgkin’s lymphoma
• Respiratory infections may trigger acute MI
• Sepsis-related mortality higher in Europe than US
• Study: SSI better predicted by distribution of body mass in obese patients
• Tdap comparable to Td vaccine, recommended for older adults
• UK funding for infectious diseases neglects most deadly illnesses
• Viral testing key to reducing inappropriate antibiotic use
• Whole-genome sequencing contained MRSA outbreak
• Zoster vaccine efficacy diminishes with time
• Court reverses conviction involving off-label promotion of drugs
• Antibiotic pipeline remains limited for pediatrics
• ASTRA: Perceived viral load status may influence behavior risk
• CHER trial: Virologic response achieved in infants with early ART
• Continued surveillance needed to monitor global HIV drug resistance
• Exhaustion of HIV therapies expected for some patients
• Experts debate when to initiate ART in asymptomatic HIV
• Incidence of sexually acquired acute HCV rising in Europe
• Lipid levels increased for patients on suppressive ART regimen
• More coinfected patients receiving treatment for acute HCV
• Neonatal herpes diagnostic evaluation updated in 2012 Red Book
• Parental discussion key to improving HPV immunization rates
• Peginterferon lambda-1a decreases viral load more quickly, safely than alfa-2a in HCV patients
• PrEP in Europe: New research under way
• Rilpivirine combo not inferior to efavirenz combo in HIV
• Triple therapy reduced HCV RNA in noncirrhotic HCV patients
• Vaginal deliveries increased in HIV women after European guideline changes